» Articles » PMID: 26725734

Insights into the Channel Gating of P2X Receptors from Structures, Dynamics and Small Molecules

Overview
Specialty Pharmacology
Date 2016 Jan 5
PMID 26725734
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

P2X receptors, as ATP-gated non-selective trimeric ion channels, are permeable to Na(+), K(+) and Ca(2+). Comparing with other ligand-gated ion channel families, P2X receptors are distinct in their unique gating properties and pathophysiological roles, and have attracted attention as promising drug targets for a variety of diseases, such as neuropathic pain, multiple sclerosis, rheumatoid arthritis and thrombus. Several small molecule inhibitors for distinct P2X subtypes have entered into clinical trials. However, many questions regarding the gating mechanism of P2X remain unsolved. The structural determinations of P2X receptors at the resting and ATP-bound open states revealed that P2X receptor gating is a cooperative allosteric process involving multiple domains, which marks the beginning of the post-structure era of P2X research at atomic level. Here, we review the current knowledge on the structure-function relationship of P2X receptors, depict the whole picture of allosteric changes during the channel gating, and summarize the active sites that may contribute to new strategies for developing novel allosteric drugs targeting P2X receptors.

Citing Articles

Implications of nociceptor receptors and immune modulation: emerging therapeutic targets for autoimmune diseases.

Fatima S, Akhtar B, Sharif A, Khan M, Shahid M, Anjum F Inflammopharmacology. 2025; .

PMID: 39955696 DOI: 10.1007/s10787-025-01653-w.


The functional role of P2 purinergic receptors in the progression of gastric cancer.

Zou F, Liu J, Zuo C, He P, Ye J, Zhang W Purinergic Signal. 2024; .

PMID: 38470513 DOI: 10.1007/s11302-024-10000-7.


Progress on functions of intracellular domain trimeric ligand-gated ion channels.

Lu Y, Lin Y, Wang J Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(2):221-230.

PMID: 38310082 PMC: 11057991. DOI: 10.3724/zdxbyxb-2023-0472.


Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles.

Mekala N, Trivedi J, Bhoj P, Togre N, Rom S, Sriram U Cell Commun Signal. 2024; 22(1):39.

PMID: 38225580 PMC: 10789007. DOI: 10.1186/s12964-023-01461-1.


Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles.

Mekala N, Trivedi J, Bhoj P, Togre N, Rom S, Sriram U Res Sq. 2023; .

PMID: 38014253 PMC: 10680944. DOI: 10.21203/rs.3.rs-3552555/v1.


References
1.
Michel A, Clay W, Ng S, Roman S, Thompson K, Condreay J . Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects. Br J Pharmacol. 2008; 155(5):738-51. PMC: 2584934. DOI: 10.1038/bjp.2008.306. View

2.
Nicke A, Baumert H, Rettinger J, Eichele A, Lambrecht G, Mutschler E . P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 1998; 17(11):3016-28. PMC: 1170641. DOI: 10.1093/emboj/17.11.3016. View

3.
Adriouch S, Bannas P, Schwarz N, Fliegert R, Guse A, Seman M . ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. FASEB J. 2007; 22(3):861-9. DOI: 10.1096/fj.07-9294com. View

4.
Keystone E, Wang M, Layton M, Hollis S, McInnes I . Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis. 2012; 71(10):1630-5. DOI: 10.1136/annrheumdis-2011-143578. View

5.
Sim J, Broomhead H, North R . Ectodomain lysines and suramin block of P2X1 receptors. J Biol Chem. 2008; 283(44):29841-6. PMC: 2573084. DOI: 10.1074/jbc.M802523200. View